 "Semaglutide, used in Ozempic, joins WHO's essential medicines list")
WHO’s latest Essential Medicines List gives semaglutide, already a buzzword in both medical and lifestyle circles, a spot among must-have drugs—a move expected to influence access and affordability worldwide.
Every two years, the World Health Organization (WHO) updates its Model List of Essential Medicines (EML). The just-released 24th edition (2025) highlights global health priorities, from infectious disease control to addressing the twin epidemics of diabetes and obesity.
Why semaglutide matters
First developed as a treatment for type 2 diabetes, semaglutide (sold under brand names like Ozempic and Wegovy) also aids in significant weight reduction, making it one of the most sought-after therapies in recent years. Its inclusion in WHO’s list is expected to put pressure on governments and health systems to make the drug more widely available—and hopefully more affordable.
For countries like India, where more than 100 million people live with diabetes and obesity is on the rise, the move could be a game-changer.
Beyond semaglutide: What else is new?
The 2025 EML goes far beyond one drug. It:
- Strengthens antibiotic stewardship through the Access, Watch, and Reserve (AWaRe) classification, promoting rational use and slowing resistance
- Expands women’s health coverage with more contraceptive options and multiple micronutrient supplements for pregnant women
- Recognises rare disease treatments, including cystic fibrosis combination therapies and medicines for Ebola and trypanosomiasis
- Adds modern immunotherapies like adalimumab (and biosimilars) for autoimmune diseases
Cancer, rare diseases, and diabetes drugs added
Some of the newly added medicines include:
- Pembrolizumab, atezolizumab, and cemiplimab for certain metastatic cancers, which met WHO’s evidence threshold of extending survival by at least four to six months
- Trikafta/Kaftrio for cystic fibrosis, a high-cost therapy long criticised for limited access
- Rapid-acting insulin analogues for types 1, 2, and gestational diabetes, rounding out WHO’s recommendations for diabetes care
Global access tool since 1977
Launched in 1977 to promote better access to medicines in developing countries, the WHO Model Lists have become a trusted global policy tool. They help shape decisions on which medicines should be prioritised for universal health coverage and public procurement.
In its latest update, the WHO Expert Committee reviewed 59 applications, including 31 for new medicines or drug classes. Following the review, 20 new medicines were added to the adult list (EML) and 15 to the children’s list (EMLc), while seven existing drugs received expanded use approvals.
With this update, the lists now feature 523 essential medicines for adults and 374 for children, reflecting today’s most urgent public health priorities. For more health updates, follow #HealthWithBS
Since you're already here
…and clearly interested in your health, take a moment to explore our varied range of stories on wellness, medical research, and public health insights.
- Men's grooming essentials Adult acne, dull skin, hair loss: Skincare tips every man should know
- What a heart doctor won’t eat 10 foods a cardiologist avoids after 20 years treating heart disease
- Early cataracts and screen stress Cataracts in 30s and 40s? How screen time and stress may be clouding vision
- Eat to prevent cardiac arrest Heart-smart eating: Diet tips to lower risk of sudden cardiac arrest
- Everyday foods linked to cancer Doctor warns against these 6 everyday foods that may raise cancer risk
- Fitness trends under the microscope Are these popular Instagram fitness trends actually helpful or just hype?
- Back pain? Walk it off Want to avoid chronic back pain? Walk over 100 minutes a day, says study
- Hidden heart hazards at work Why your office coffee cup and lunch box may raise heart disease risks
- How to be heard at work Speak up at work: What to do when you're feeling ignored and invisible
- Beyond sobriety: Addiction recovery Why recovery from addiction needs more than just quitting substances
This content is for informational purposes only and is not a substitute for professional medical advice.